Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integer Holdings (ITGR) Asset Writedowns and Impairment (2021 - 2024)

Integer Holdings recorded quarterly Asset Writedowns and Impairment of $1.1 million in Q1 2024, up 78.98% quarter-over-quarter from $590000.0 in Q4 2023.

Integer Holdings' Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $1.1 million for Q1 2024.

  • In Q1 2024, Asset Writedowns and Impairment changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2024 stood at $1.1 million (up 78.98% YoY), while the FY2024 annual figure was $1.1 million, up 78.98% from the prior year.
  • Asset Writedowns and Impairment came in at $1.1 million for Q1 2024 at Integer Holdings, up from $590000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.1 million in Q1 2024 to a low of $301000.0 in Q4 2021.
  • A 4-year average of $686250.0 and a median of $694000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Integer Holdings 3.11 Bn 3.11 Bn 109.60 Mn

Historic Data

Download Data 🔒
DateValue
Mar 29, 2024 1.06 Mn
Mar 29, 2024 1.06 Mn
Dec 31, 2023 590,000.00
Dec 31, 2023 590,000.00
Apr 1, 2022 798,000.00
Apr 1, 2022 798,000.00
Dec 31, 2021 301,000.00
Dec 31, 2021 301,000.00